Ashley Gallagher, Associate Editor

If approved, empagliflozin would be the first therapy proven to significantly improve outcomes for individuals with heart failure, according to Boehringer Ingelheim.

They are attempting to determine the associations and connections to further benefit individuals using the therapies.

Study results show no differences in the rate of neuropathic pain, surgical site infection, wound-related complications, or other complications between the 2 groups.

After adjusting for age, education level, and gender, each 1-point increase in dietary inflammatory score was linked to a 21% increase in cognitive impairment, study results show.

PRISM-EXT shows data consistent with those of PRISM3, which provided significant improvement compared with the placebo through 8 weeks and 24 weeks post-treatment.

The report also describes the benefits of interventions at the family, individual, institutional, organizational, and policy levels and differentiates AD from other types of dementia.

It is an FDA-approved-agent agnostic approach to gathering routine clinical practice data and outcomes for sharing and transparency.

Peer Exchange panel discusses pharmacists' role in recommending systemic and topical agents.

Regularly testing before and during chemotherapy can help physicians determine early on if treatment is working.

The study results also show that strokes were far more common among traditional smokers.

But expanding coverage in 2014 was associated with a notable increase in enrollment among individuals with heart failure, study results show.

Individuals taking erenumab had a 55.4% reduction from baseline in their monthly migraine days, results from HER-MES show.

Study results show that those with lymphoproliferative disorders are the most likely to develop the virus after vaccination.

Penn State investigators have found that foods with 6.5 grams, or about 1.3 teaspoons, were linked to reducing hypertension after 4 weeks.

The company’s decision to take melphalan flufenamide off the market was made after dialogue and interactions with the FDA.

The company plans to submit data to the European Medicines Agency, FDA, and other global regulators.

The new drug application submission of parsaclisib (Incyte) was based on data from several phase 2 studies that evaluate the treatment.

Kaushal Nanavati, MD, assistant dean of wellness and director of integrative medicine and survivorship at the Upstate Cancer Center discusses what the different kinds or research shows about integrative medicine and the potential risk of this treatment.

Paolo Raggi, MD, PhD, professor at the department of medicine in the division of cardiology at the University of Alberta, discusses how chronic kidney disease elevated the risk of vascular calcification and what the risks of vascular calcification are.

In a clinical study of healthy adults, Dyanavel XR tablets were deemed to be bioequivalent to amphetamine extended-release oral suspension in patients with ADHD.

Structural changes to the COVID-19 virus highlight the need to expand the research efforts.

Results of a study by the American Heart Association show a genetic predisposition may lead to an association between sleeplessness and brain bleeding.

In a report, the World Health Organization and a partner ask developers, funders, and investigators to accelerate developing a vaccination.

The difference between individuals who were vaccinated and had the infection were higher at different intervals than for those who were unvaccinated.

A new poll shows that this year 64% of individuals between aged 50 and 64 years say they already got or are likely to get their influenza shots up from 54% last year.

The AHA emphasizes the importance of looking at a total dietary pattern, including amounts, balance, combinations, and variety of beverages and food consumer regularly.

The results also showed they were nearly 20 times more effective at preventing hospitalizations from the virus for individuals older than 65 than a prior infection alone.

The results of a study show that individuals who received 3 doses of the BNT162b2 vaccine had a 93% lower risk of hospitalization than those who had just 2.

Agency gives green light to supplemental new drug application for repository corticotropin injection.

Among those who were infected with the delta variant (126), 25% were fully immunized and 38% were unvaccinated, study results show.